Abstract
Aim:
To investigate the metabolic effects of recombinant human growth hormone (rhGH) in an Alström syndrome patient with growth hormone deficiency.
Methods:
A 15-year-old Alström syndrome boy with growth hormone deficiency received rhGH therapy for 1 year. Biochemical parameters, including hepatic enzyme levels, lipid profiles, and insulin sensitivity, were measured. Body composition analysis and computed tomography scans of the liver were performed.
Results:
After 1 year of rhGH treatment, body fat mass, fat infiltration in the liver, and serum lipid profiles had all decreased. Insulin sensitivity and acanthosis nigricans improved.
Conclusion:
rhGH therapy might have beneficial effects on body composition, liver fat content, lipid profiles, and insulin resistance in Alström syndrome patients, with improvement of the glucose homeostasis.
Copyright 2003 S. Karger AG, Basel
MeSH terms
-
Abnormalities, Multiple / drug therapy*
-
Abnormalities, Multiple / genetics*
-
Acanthosis Nigricans / complications
-
Acanthosis Nigricans / diagnosis
-
Acanthosis Nigricans / drug therapy
-
Adipose Tissue
-
Adolescent
-
Blood Glucose / drug effects
-
Blood Glucose / physiology
-
Body Composition / drug effects
-
Body Mass Index
-
Chromosome Disorders / complications
-
Chromosome Disorders / drug therapy*
-
Chromosome Disorders / genetics*
-
Diagnostic Tests, Routine
-
Fatty Liver / diagnosis
-
Fatty Liver / drug therapy
-
Fatty Liver / enzymology
-
Genes, Recessive
-
Growth Hormone / administration & dosage
-
Growth Hormone / pharmacology
-
Growth Hormone / therapeutic use*
-
Human Growth Hormone / adverse effects
-
Human Growth Hormone / deficiency
-
Humans
-
Hyperinsulinism / complications
-
Hyperinsulinism / diagnosis
-
Hypertriglyceridemia / complications
-
Hypertriglyceridemia / diagnosis
-
Metabolism / drug effects*
-
Syndrome
-
Time Factors
-
Tomography, X-Ray Computed
Substances
-
Blood Glucose
-
Human Growth Hormone
-
Growth Hormone